Gabapentin for Management of Recurrent Pain in 22 Nonverbal Children with Severe Neurological Impairment: A Retrospective Analysis

Journal of Palliative Medicine

Volumn 18, Issue 5, 2015, Pages 453-456

  Hauer, Julie M ^a   Solodiuk, Jean C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE; DANTROLENE; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METHADONE; PROTON PUMP INHIBITOR; VENLAFAXINE; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MUSCLE TONE; NOCICEPTIVE PAIN; PAIN; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPASTICITY; VOMITING; WEIGHT GAIN; ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM DISEASES; COMPLICATION; INFANT; LONG TERM CARE; NONVERBAL COMMUNICATION; PAIN MEASUREMENT; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AMINES; ANALGESICS; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; LONG-TERM CARE; MALE; NONVERBAL COMMUNICATION; PAIN; PAIN MEASUREMENT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84930006154     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2014.0359     Document Type: Article

References (15)

1. Breau LM, Camfield CS, McGrath PJ, Finley GA: The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med 2003;157:1219-1226.
2. Houlihan CM, O'Donnell M, Conaway M, Stevenson RD: Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol 2004;46:305-310.
3. Hunt A, Goldman A, Seers K, et al.: Clinical validation of the paediatric pain profile. Dev Med Child Neurol 2004;46:9-18.
4. Malviya S, Voepel-Lewis T, Burke C, et al.: The revised FLACC observational pain tool: Improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth 2006;16:258-265.
5. Solodiuk JC, Scott-Sutherland J, Meyers M, et al.: Validation of the Individualized Numeric Rating Scale (INRS): A pain assessment tool for nonverbal children with intellectual disability. Pain 2010;150:231-236.
6. Haig GM, Bockbrader HN, Wesche DL, et al.: Single-dose gabapentin pharmacokinetics and safety in healthy infants and children. J Clin Pharmacol 2001;41:507-514.
7. Korn-Merker E, Borusiak P, Boenigk HE: Gabapentin in childhood epilepsy: A prospective evaluation of efficacy and safety. Epilepsy Res 2000;38:27-32.
8. Hauer J, Wical B, Charnas L: Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics 2007;119:e519-e522.
9. Lauder GR, White MC: Neuropathic pain following multilevel surgery in children with cerebral palsy: A case series and review. Paediatr Anaesth 2005;15:412-420.
10. Nicholson BD: Evaluation and treatment of central pain syndromes. Neurology 2004;62:S30-S36.
11. Baguley IJ, Heriseanu RE, Gurka JA, et al.: Gabapentin in the management of dysautonomia following severe traumatic brain injury: A case series. J Neurol Neurosurg Psychiatry 2007;78:539-541.
12. Zangen T, Ciarla C, Zangen S, et al.: Gastrointestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers. J Pediatr Gastroenterol Nutr 2003;37:287-293.
13. Mousa H, Caniano DA, Alhajj M, et al.: Effect of Nissen fundoplication on gastric motor and sensory functions. J Pediatr Gastroenterol Nutr 2006;43:185-189.
14. Axelrod FB, Berlin D: Pregabalin: A new approach to treatment of the dysautonomic crisis. Pediatrics 2009;124:743-746.
15. nd ed. Philadelphia, PA: Williams & Wilkins, 1989.